Sign inJoin waitlistJoin the waitlist

AS

Alexander Starodub

Credentials: · · · · ·

History

Duke University
2006–2009
Internal Medicine
2003–2006
Ohio State University College of Medicine
1999–2003

Research

Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket…
Annals of Oncology · 2021 · 354 citations
Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer
Journal of Clinical Oncology · 2017 · 347 citations
First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors
Clinical Cancer Research · 2015 · First of 13 authors · 286 citations

WW
William Wegener
8 papers
Allyson Ocean
7 papers
MG
Michael Guarino
7 papers
Jordan Berlin
6 papers
Wells Messersmith
6 papers
HH
Herbert Hurwitz
5 papers
JB
Johanna Bendell
5 papers
Michael Morse
5 papers
Aditya Bardia
4 papers
Hope Uronis
4 papers
Linda Vahdat
4 papers
Manish Shah
4 papers